Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Abeona issues letter to shareholders on 2022 anticipated milestones » 07:37
12/22/21
12/22
07:37
12/22/21
07:37
ABEO

Abeona Therapeutics

/

+

Abeona Therapeutics…

Abeona Therapeutics issued the following letter to shareholders. Vish Seshadri, Chief Executive Officer, wrote, "Dear fellow shareholders, We have never been closer to fulfilling our mission of providing novel gene and cell therapies to patients who currently have no approved treatment options as we continue to advance the EB-101 and ABO-102 pivotal studies toward completion to support two U.S. Biologics License Application submissions. At the same time, we are continuing to make steady progress with other clinical and preclinical programs. As we end the calendar year 2021, it is important to reflect on all that we at Abeona have achieved over the last 12 months, and it is even more crucial to look ahead at the opportunities awaiting us in 2022 and beyond... Well-positioned for 2022 Anticipated Milestones... we expect to begin 2022 with cash and financial resources of more than $50M. We believe focusing on our milestones is the best way to create value for our shareholders, and our strengthened balance sheet is crucial in positioning us to further execute our operating plan and achieve important anticipated milestones. Our anticipated milestones in 2022 include: EB-101 - Completion of patient enrollment for the EB-101 Phase 3 VIITAL study in the first quarter of 2022. Top-line VIITAL study results in the third quarter of 2022. ABO-102 - Construct and operationalize the new AAV manufacturing facility in 2022. Top-line results for MPS IIIA Transpher A study between the fourth quarter of 2022 and second quarter of 2023. ABO-101 - Two-year neurocognitive data from MPS IIIB Transpher B study in the second half of 2022. Preclinical Pipeline - Generate proof-of-concept data assessing AAV capsids in multiple undisclosed eye indications beginning in the first half of 2022. Pre-IND meeting with FDA in the second half of 2022."

ShowHide Related Items >><<
ABEO Abeona Therapeutics
/

+

ABEO Abeona Therapeutics
/

+

11/30/21 SVB Leerink
Abeona Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
11/29/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $4 from $5 at H.C. Wainwright
07/19/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $5 from $8 at H.C. Wainwright
ABEO Abeona Therapeutics
/

+

  • 17
    Dec
Hot Stocks
Abeona Therapeutics prices public offering of 44.7M shares of common stock » 09:01
12/17/21
12/17
09:01
12/17/21
09:01
ABEO

Abeona Therapeutics

/

+

Abeona Therapeutics…

Abeona Therapeutics announced the pricing of its underwritten public offering of 44,700,000 shares of its common stock and warrants to purchase 44,700,000 shares of its common stock at a combined offering price to the public of $0.39 per one share of common stock and one warrant to purchase one share of common stock. The warrants have an exercise price of $0.39 per share of common stock, are exercisable immediately, and will expire five years from the date of issuance. The aggregate gross proceeds from the offering are expected to be approximately $17.5 million, before deducting the underwriting discounts and commissions and other offering expenses payable by Abeona. The offering is expected to close on December 21, 2021, subject to the satisfaction of customary closing conditions. Cantor Fitzgerald & Co. is acting as sole book-running manager for the offering, and A.G.P./Alliance Global Partners is acting as lead manager for the offering. Abeona intends to use the net proceeds of the offering to fund continued clinical development of pipeline products, as well as for working capital and corporate purposes.

ShowHide Related Items >><<
ABEO Abeona Therapeutics
/

+

ABEO Abeona Therapeutics
/

+

11/30/21 SVB Leerink
Abeona Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
11/29/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $4 from $5 at H.C. Wainwright
07/19/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $5 from $8 at H.C. Wainwright
ABEO Abeona Therapeutics
/

+

  • 17
    Dec
Syndicate
Abeona Therapeutics announces offering of common stock, warrants » 16:02
12/16/21
12/16
16:02
12/16/21
16:02
ABEO

Abeona Therapeutics

/

+

Abeona Therapeutics …

Abeona Therapeutics announced that it intends to offer and sell shares of its common stock and warrants to purchase common stock in an underwritten public offering pursuant to an existing shelf registration statement. Abeona intends to use the net proceeds of the offering to fund continued clinical development of pipeline products, as well as for working capital and corporate purposes. Cantor Fitzgerald & Co. is acting as sole book-running manager for the offering, and A.G.P./Alliance Global Partners is acting as lead manager for the offering.

ShowHide Related Items >><<
ABEO Abeona Therapeutics
/

+

ABEO Abeona Therapeutics
/

+

11/30/21 SVB Leerink
Abeona Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
11/29/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $4 from $5 at H.C. Wainwright
07/19/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $5 from $8 at H.C. Wainwright
ABEO Abeona Therapeutics
/

+

Conference/Events
Piper Sandler to hold a virtual conference » 04:55
12/02/21
12/02
04:55
12/02/21
04:55
ABEO

Abeona Therapeutics

/

+

, AQST

Aquestive Therapeutics

$5.67 /

-0.24 (-4.06%)

, BXRX

Baudax Bio

/

+

, CYTK

Cytokinetics

$36.93 /

-2.49 (-6.32%)

, CUE

Cue Biopharma

$11.46 /

-0.795 (-6.49%)

, DOCS

Doximity

$64.67 /

-2.945 (-4.36%)

, DMAC

DiaMedica Therapeutics

$3.70 /

+ (+0.00%)

, DICE

Dice Therapeutics

$31.07 /

-0.62 (-1.96%)

, FLDM

Fluidigm

$4.40 /

-0.22 (-4.76%)

, GBT

Global Blood Therapeutics

$27.14 /

-1.16 (-4.10%)

, IMTX

Immatics

$11.19 /

-0.2 (-1.76%)

, HALO

Halozyme

$32.19 /

-0.72 (-2.19%)

, IOVA

Iovance Biotherapeutics

$17.60 /

-1.12 (-5.98%)

, MDXG

MiMedx

$6.92 /

-0.075 (-1.07%)

, NUVA

NuVasive

$47.98 /

-0.04 (-0.08%)

, ONTX

Onconova

$2.74 /

-0.265 (-8.82%)

, PSNL

Personalis

$13.06 /

-0.56 (-4.11%)

, QDEL

Quidel

$144.74 /

-2.76 (-1.87%)

, REGN

Regeneron

$630.74 /

-5.67 (-0.89%)

, RVNC

Revance

$14.21 /

+0.51 (+3.72%)

, SEER

Seer

$21.09 /

-1.18 (-5.30%)

, SNSE

Sensei Biotherapeutics

$6.78 /

-0.11 (-1.60%)

, TFX

Teleflex

$289.46 /

-7.82 (-2.63%)

, TNYA

Tenaya Therapeutics

$19.59 /

-0.28 (-1.41%)

, VIVO

Meridian Bioscience

$19.59 /

-0.33 (-1.66%)

33rd Annual Healthcare…

33rd Annual Healthcare Virtual Conference to be held on November 29-December 2.

ShowHide Related Items >><<
VIVO Meridian Bioscience
$19.59 /

-0.33 (-1.66%)

TFX Teleflex
$289.46 /

-7.82 (-2.63%)

SNSE Sensei Biotherapeutics
$6.78 /

-0.11 (-1.60%)

SEER Seer
$21.09 /

-1.18 (-5.30%)

RVNC Revance
$14.21 /

+0.51 (+3.72%)

REGN Regeneron
$630.74 /

-5.67 (-0.89%)

QDEL Quidel
$144.74 /

-2.76 (-1.87%)

PSNL Personalis
$13.06 /

-0.56 (-4.11%)

ONTX Onconova
$2.74 /

-0.265 (-8.82%)

NUVA NuVasive
$47.98 /

-0.04 (-0.08%)

MDXG MiMedx
$6.92 /

-0.075 (-1.07%)

IOVA Iovance Biotherapeutics
$17.60 /

-1.12 (-5.98%)

IMTX Immatics
$11.19 /

-0.2 (-1.76%)

HALO Halozyme
$32.19 /

-0.72 (-2.19%)

GBT Global Blood Therapeutics
$27.14 /

-1.16 (-4.10%)

FLDM Fluidigm
$4.40 /

-0.22 (-4.76%)

DOCS Doximity
$64.67 /

-2.945 (-4.36%)

DMAC DiaMedica Therapeutics
$3.70 /

+ (+0.00%)

DICE Dice Therapeutics
$31.07 /

-0.62 (-1.96%)

CYTK Cytokinetics
$36.93 /

-2.49 (-6.32%)

CUE Cue Biopharma
$11.46 /

-0.795 (-6.49%)

BXRX Baudax Bio
/

+

AQST Aquestive Therapeutics
$5.67 /

-0.24 (-4.06%)

ABEO Abeona Therapeutics
/

+

ABEO Abeona Therapeutics
/

+

11/30/21 SVB Leerink
Abeona Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
11/29/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $4 from $5 at H.C. Wainwright
07/19/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $5 from $8 at H.C. Wainwright
AQST Aquestive Therapeutics
$5.67 /

-0.24 (-4.06%)

06/24/21 Lake Street
Aquestive approval likely by year-end after Libervant NDA, says Lake Street
04/06/21 RBC Capital
Aquestive Therapeutics transferred with an Outperform at RBC Capital
BXRX Baudax Bio
/

+

CYTK Cytokinetics
$36.93 /

-2.49 (-6.32%)

12/01/21 Mizuho
Cytokinetics price target raised to $54 from $45 at Mizuho
11/04/21 H.C. Wainwright
Cytokinetics price target raised to $62 from $58 at H.C. Wainwright
10/12/21 Cantor Fitzgerald
Cytokinetics price target raised to $57 from $48 at Cantor Fitzgerald
10/06/21 Jefferies
Cytokinetics initiated with a Buy at Jefferies
CUE Cue Biopharma
$11.46 /

-0.795 (-6.49%)

DOCS Doximity
$64.67 /

-2.945 (-4.36%)

12/01/21 Jefferies
Doximity initiated with a Buy at Jefferies
11/16/21 Baird
Baird starts 'unique asset' Doximity with Outperform, $84 target
11/16/21 Baird
Doximity initiated with an Outperform at Baird
11/10/21 Needham
Doximity price target raised to $90 from $62 at Needham
DMAC DiaMedica Therapeutics
$3.70 /

+ (+0.00%)

09/27/21 Roth Capital
DiaMedica price target lowered to $24 from $32 at Roth Capital
06/30/21 Maxim
DiaMedica Therapeutics price target lowered to $11 from $14 at Maxim
06/29/21 Lake Street
DiaMedica should be bought on weakness after CKD data, says Lake Street
06/29/21 Roth Capital
DiaMedica Therapeutics price target lowered to $32 from $38 at Roth Capital
DICE Dice Therapeutics
$31.07 /

-0.62 (-1.96%)

10/11/21 SVB Leerink
Dice Therapeutics initiated with an Outperform at SVB Leerink
10/11/21 Evercore ISI
Evercore ISI starts Dice Therapeutics at Outperform, sees 120% upside
10/11/21 BofA
Dice Therapeutics initiated with a Buy at BofA
10/11/21 Evercore ISI
Dice Therapeutics initiated with an Outperform at Evercore ISI
FLDM Fluidigm
$4.40 /

-0.22 (-4.76%)

05/12/21 Piper Sandler
Fluidigm price target lowered to $7 from $8 at Piper Sandler
02/11/21 Piper Sandler
Fluidigm price target lowered to $8 from $15 at Piper Sandler
12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
GBT Global Blood Therapeutics
$27.14 /

-1.16 (-4.10%)

10/06/21 Jefferies
Global Blood Therapeutics initiated with a Buy at Jefferies
08/04/21
Fly Intel: Top five analyst upgrades
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
IMTX Immatics
$11.19 /

-0.2 (-1.76%)

03/17/21 Chardan
Immatics' early TCR platform activity signals 'notable,' says Chardan
03/17/21 SVB Leerink
Immatics price target raised to $26 from $17 at SVB Leerink
HALO Halozyme
$32.19 /

-0.72 (-2.19%)

06/14/21
Fly Intel: Top five analyst initiations
06/14/21 Evercore ISI
Halozyme initiated with an Outperform at Evercore ISI
06/11/21 BMO Capital
Halozyme coverage transferred at BMO Capital
05/17/21 SVB Leerink
Halozyme initiated with an Outperform at SVB Leerink
IOVA Iovance Biotherapeutics
$17.60 /

-1.12 (-5.98%)

11/15/21 Oppenheimer
Iovance price target lowered to $31 from $38 at Oppenheimer
11/05/21 H.C. Wainwright
Iovance Biotherapeutics price target lowered to $43 from $46 at H.C. Wainwright
11/05/21 Piper Sandler
Iovance Biotherapeutics price target raised to $20 from $18 at Piper Sandler
06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
MDXG MiMedx
$6.92 /

-0.075 (-1.07%)

07/26/21 Northland
MiMedx initiated with an Outperform at Northland
03/19/21 H.C. Wainwright
MiMedx initiated with a Buy at H.C. Wainwright
NUVA NuVasive
$47.98 /

-0.04 (-0.08%)

11/15/21 Piper Sandler
Piper sees 'low' odds that Globus will try to buy NuVasive
11/10/21 Needham
NuVasive price target lowered to $64 from $73 at Needham
11/10/21 Citi
NuVasive price target lowered to $70 from $82 at Citi
10/28/21 Loop Capital
NuVasive initiated with a Hold at Loop Capital
ONTX Onconova
$2.74 /

-0.265 (-8.82%)

09/28/21 Guggenheim
Onconova price target lowered to $12 from $29 at Guggenheim
05/18/21 Guggenheim
Onconova initiated with a Buy at Guggenheim
12/22/20 Noble Capital
Onconova upgraded to Outperform from Market Perform at Noble Capital
PSNL Personalis
$13.06 /

-0.56 (-4.11%)

11/05/21 Morgan Stanley
Morgan Stanley downgrades Personalis, says upside unlikely until 2023
11/05/21 Morgan Stanley
Personalis downgraded to Equal Weight from Overweight at Morgan Stanley
11/03/21 Needham
Personalis downgraded to Hold from Buy at Needham
11/03/21 Needham
Personalis downgraded to Hold from Buy at Needham
QDEL Quidel
$144.74 /

-2.76 (-1.87%)

10/08/21 JPMorgan
Quidel price target raised to $80 from $70 at JPMorgan
09/17/21 Raymond James
U.S. contract awards 'major wins' for Quidel, OraSure, says Raymond James
07/26/21 Piper Sandler
Quidel agreement with Beckman removes overhang, says Piper Sandler
07/19/21 Raymond James
Quidel contract with Delaware could increase materially, says Raymond James
REGN Regeneron
$630.74 /

-5.67 (-0.89%)

11/30/21 H.C. Wainwright
Regeneron should be bought on today's selloff, says H.C. Wainwright
11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/18/21 BMO Capital
Regeneron assumed with an Outperform at BMO Capital
11/10/21 Cantor Fitzgerald
Regeneron price target raised to $760 from $700 at Cantor Fitzgerald
RVNC Revance
$14.21 /

+0.51 (+3.72%)

10/26/21 Barclays
Revance price target lowered to $22 from $33 at Barclays
10/25/21 Wells Fargo
Revance downgraded to Equal Weight from Overweight at Wells Fargo
10/25/21 Wells Fargo
Revance downgraded to Equal Weight from Overweight at Wells Fargo
10/18/21 Needham
Revance price target lowered to $25 from $45 at Needham
SEER Seer
$21.09 /

-1.18 (-5.30%)

10/14/21 Cowen
Seer coverage transferred at Cowen
08/13/21 Morgan Stanley
Seer price target lowered to $50 from $55 at Morgan Stanley
12/29/20 BofA
BofA starts Seer with Neutral after 239% post-IPO rally
12/29/20
Fly Intel: Top five analyst calls
SNSE Sensei Biotherapeutics
$6.78 /

-0.11 (-1.60%)

07/06/21 Piper Sandler
Sensei Biotherapeutics price target lowered to $12 from $25 at Piper Sandler
07/05/21 AlphaValue/Baader
Sensei Biotherapeutics downgraded to Add from Buy at AlphaValue
07/01/21 Berenberg
Berenberg downgrades Sensei to Hold on 'significant setback'
07/01/21 Berenberg
Sensei Biotherapeutics downgraded to Hold from Buy at Berenberg
TFX Teleflex
$289.46 /

-7.82 (-2.63%)

11/03/21 Piper Sandler
Glaukos 'big beneficiary' of final CMS ruling, says Piper Sandler
10/07/21
Fly Intel: Top five analyst downgrades
10/07/21 KeyBanc
KeyBanc downgrades Teleflex on lower UroLift visibility
10/07/21 KeyBanc
Teleflex downgraded to Sector Weight from Overweight at KeyBanc
TNYA Tenaya Therapeutics
$19.59 /

-0.28 (-1.41%)

10/25/21 Piper Sandler
Conviction in Tenaya Therapeutics stronger after ESGCT data, says Piper Sandler
08/24/21 Morgan Stanley
Tenaya Therapeutics initiated with an Overweight at Morgan Stanley
08/24/21 Chardan
Tenaya Therapeutics initiated with a Buy at Chardan
08/24/21 Morgan Stanley
Tenaya Therapeutics initiated with an Overweight at Morgan Stanley
VIVO Meridian Bioscience
$19.59 /

-0.33 (-1.66%)

02/24/21 H.C. Wainwright
Meridian Bioscience price target lowered to $32 from $34 at H.C. Wainwright
02/23/21 Piper Sandler
Piper keeps Overweight on Meridian Bioscience after EUA withdrawal
02/08/21 H.C. Wainwright
Meridian Bioscience price target raised to $34 from $30 at H.C. Wainwright
02/08/21 Piper Sandler
Meridian Bioscience price target raised to $34 from $26 at Piper Sandler
VIVO Meridian Bioscience
$19.59 /

-0.33 (-1.66%)

TNYA Tenaya Therapeutics
$19.59 /

-0.28 (-1.41%)

TFX Teleflex
$289.46 /

-7.82 (-2.63%)

SNSE Sensei Biotherapeutics
$6.78 /

-0.11 (-1.60%)

SEER Seer
$21.09 /

-1.18 (-5.30%)

RVNC Revance
$14.21 /

+0.51 (+3.72%)

REGN Regeneron
$630.74 /

-5.67 (-0.89%)

QDEL Quidel
$144.74 /

-2.76 (-1.87%)

PSNL Personalis
$13.06 /

-0.56 (-4.11%)

NUVA NuVasive
$47.98 /

-0.04 (-0.08%)

IOVA Iovance Biotherapeutics
$17.60 /

-1.12 (-5.98%)

IMTX Immatics
$11.19 /

-0.2 (-1.76%)

HALO Halozyme
$32.19 /

-0.72 (-2.19%)

GBT Global Blood Therapeutics
$27.14 /

-1.16 (-4.10%)

FLDM Fluidigm
$4.40 /

-0.22 (-4.76%)

DOCS Doximity
$64.67 /

-2.945 (-4.36%)

DMAC DiaMedica Therapeutics
$3.70 /

+ (+0.00%)

DICE Dice Therapeutics
$31.07 /

-0.62 (-1.96%)

CYTK Cytokinetics
$36.93 /

-2.49 (-6.32%)

CUE Cue Biopharma
$11.46 /

-0.795 (-6.49%)

BXRX Baudax Bio
/

+

AQST Aquestive Therapeutics
$5.67 /

-0.24 (-4.06%)

ABEO Abeona Therapeutics
/

+

  • 24
    Sep
  • 15
    Sep
  • 30
    Jul
  • 21
    Jul
  • 24
    Jun
  • 11
    Feb
  • 04
    Feb
  • 27
    Jan
  • 28
    Jan
  • 04
    Dec
SEER Seer
$21.09 /

-1.18 (-5.30%)

REGN Regeneron
$630.74 /

-5.67 (-0.89%)

QDEL Quidel
$144.74 /

-2.76 (-1.87%)

NUVA NuVasive
$47.98 /

-0.04 (-0.08%)

FLDM Fluidigm
$4.40 /

-0.22 (-4.76%)

DOCS Doximity
$64.67 /

-2.945 (-4.36%)

VIVO Meridian Bioscience
$19.59 /

-0.33 (-1.66%)

TNYA Tenaya Therapeutics
$19.59 /

-0.28 (-1.41%)

TFX Teleflex
$289.46 /

-7.82 (-2.63%)

SNSE Sensei Biotherapeutics
$6.78 /

-0.11 (-1.60%)

SEER Seer
$21.09 /

-1.18 (-5.30%)

RVNC Revance
$14.21 /

+0.51 (+3.72%)

REGN Regeneron
$630.74 /

-5.67 (-0.89%)

QDEL Quidel
$144.74 /

-2.76 (-1.87%)

PSNL Personalis
$13.06 /

-0.56 (-4.11%)

ONTX Onconova
$2.74 /

-0.265 (-8.82%)

NUVA NuVasive
$47.98 /

-0.04 (-0.08%)

IOVA Iovance Biotherapeutics
$17.60 /

-1.12 (-5.98%)

HALO Halozyme
$32.19 /

-0.72 (-2.19%)

GBT Global Blood Therapeutics
$27.14 /

-1.16 (-4.10%)

FLDM Fluidigm
$4.40 /

-0.22 (-4.76%)

DOCS Doximity
$64.67 /

-2.945 (-4.36%)

DMAC DiaMedica Therapeutics
$3.70 /

+ (+0.00%)

DICE Dice Therapeutics
$31.07 /

-0.62 (-1.96%)

CYTK Cytokinetics
$36.93 /

-2.49 (-6.32%)

BXRX Baudax Bio
/

+

REGN Regeneron
$630.74 /

-5.67 (-0.89%)

IOVA Iovance Biotherapeutics
$17.60 /

-1.12 (-5.98%)

IMTX Immatics
$11.19 /

-0.2 (-1.76%)

DOCS Doximity
$64.67 /

-2.945 (-4.36%)

Conference/Events
Piper Sandler to hold a virtual conference » 04:55
12/01/21
12/01
04:55
12/01/21
04:55
ABEO

Abeona Therapeutics

/

+

, AQST

Aquestive Therapeutics

$5.91 /

-0.16 (-2.64%)

, BXRX

Baudax Bio

/

+

, CYTK

Cytokinetics

$39.30 /

+0.51 (+1.31%)

, CUE

Cue Biopharma

$12.27 /

+0.24 (+2.00%)

, DOCS

Doximity

$67.60 /

+0.91 (+1.36%)

, DMAC

DiaMedica Therapeutics

$3.69 /

+0.05 (+1.37%)

, DICE

Dice Therapeutics

$31.69 /

+0.21 (+0.67%)

, FLDM

Fluidigm

$4.62 /

+0.115 (+2.55%)

, GBT

Global Blood Therapeutics

$28.30 /

+0.31 (+1.11%)

, IMTX

Immatics

$11.39 /

+0.07 (+0.62%)

, HALO

Halozyme

$32.89 /

-0.425 (-1.28%)

, IOVA

Iovance Biotherapeutics

$18.70 /

+0.445 (+2.44%)

, MDXG

MiMedx

$7.00 /

-0.155 (-2.17%)

, NUVA

NuVasive

$48.02 /

-1.19 (-2.42%)

, ONTX

Onconova

$3.01 /

-0.05 (-1.63%)

, PSNL

Personalis

$13.58 /

-0.175 (-1.27%)

, QDEL

Quidel

$147.25 /

-2.36 (-1.58%)

, REGN

Regeneron

$636.37 /

-17.98 (-2.75%)

, RVNC

Revance

$13.69 /

+1.24 (+9.96%)

, SEER

Seer

$22.29 /

+0.76 (+3.53%)

, SNSE

Sensei Biotherapeutics

$6.93 /

+0.16 (+2.36%)

, TFX

Teleflex

$297.56 /

-11.39 (-3.69%)

, TNYA

Tenaya Therapeutics

$19.87 /

+1.17 (+6.26%)

, VIVO

Meridian Bioscience

$19.91 /

-0.17 (-0.85%)

33rd Annual Healthcare…

33rd Annual Healthcare Virtual Conference to be held on November 29-December 2.

ShowHide Related Items >><<
VIVO Meridian Bioscience
$19.91 /

-0.17 (-0.85%)

TFX Teleflex
$297.56 /

-11.39 (-3.69%)

SNSE Sensei Biotherapeutics
$6.93 /

+0.16 (+2.36%)

SEER Seer
$22.29 /

+0.76 (+3.53%)

RVNC Revance
$13.69 /

+1.24 (+9.96%)

REGN Regeneron
$636.37 /

-17.98 (-2.75%)

QDEL Quidel
$147.25 /

-2.36 (-1.58%)

PSNL Personalis
$13.58 /

-0.175 (-1.27%)

ONTX Onconova
$3.01 /

-0.05 (-1.63%)

NUVA NuVasive
$48.02 /

-1.19 (-2.42%)

MDXG MiMedx
$7.00 /

-0.155 (-2.17%)

IOVA Iovance Biotherapeutics
$18.70 /

+0.445 (+2.44%)

IMTX Immatics
$11.39 /

+0.07 (+0.62%)

HALO Halozyme
$32.89 /

-0.425 (-1.28%)

GBT Global Blood Therapeutics
$28.30 /

+0.31 (+1.11%)

FLDM Fluidigm
$4.62 /

+0.115 (+2.55%)

DOCS Doximity
$67.60 /

+0.91 (+1.36%)

DMAC DiaMedica Therapeutics
$3.69 /

+0.05 (+1.37%)

DICE Dice Therapeutics
$31.69 /

+0.21 (+0.67%)

CYTK Cytokinetics
$39.30 /

+0.51 (+1.31%)

CUE Cue Biopharma
$12.27 /

+0.24 (+2.00%)

BXRX Baudax Bio
/

+

AQST Aquestive Therapeutics
$5.91 /

-0.16 (-2.64%)

ABEO Abeona Therapeutics
/

+

ABEO Abeona Therapeutics
/

+

11/30/21 SVB Leerink
Abeona Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
11/29/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $4 from $5 at H.C. Wainwright
07/19/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $5 from $8 at H.C. Wainwright
AQST Aquestive Therapeutics
$5.91 /

-0.16 (-2.64%)

06/24/21 Lake Street
Aquestive approval likely by year-end after Libervant NDA, says Lake Street
04/06/21 RBC Capital
Aquestive Therapeutics transferred with an Outperform at RBC Capital
BXRX Baudax Bio
/

+

CYTK Cytokinetics
$39.30 /

+0.51 (+1.31%)

11/04/21 H.C. Wainwright
Cytokinetics price target raised to $62 from $58 at H.C. Wainwright
10/12/21 Cantor Fitzgerald
Cytokinetics price target raised to $57 from $48 at Cantor Fitzgerald
10/06/21 Jefferies
Cytokinetics initiated with a Buy at Jefferies
10/04/21 Piper Sandler
Cytokinetics set to make commercial impact, says Piper Sandler
CUE Cue Biopharma
$12.27 /

+0.24 (+2.00%)

DOCS Doximity
$67.60 /

+0.91 (+1.36%)

11/16/21 Baird
Baird starts 'unique asset' Doximity with Outperform, $84 target
11/16/21 Baird
Doximity initiated with an Outperform at Baird
11/10/21 Needham
Doximity price target raised to $90 from $62 at Needham
11/10/21 Canaccord
Doximity price target raised to $75 from $70 at Canaccord
DMAC DiaMedica Therapeutics
$3.69 /

+0.05 (+1.37%)

09/27/21 Roth Capital
DiaMedica price target lowered to $24 from $32 at Roth Capital
06/30/21 Maxim
DiaMedica Therapeutics price target lowered to $11 from $14 at Maxim
06/29/21 Lake Street
DiaMedica should be bought on weakness after CKD data, says Lake Street
06/29/21 Roth Capital
DiaMedica Therapeutics price target lowered to $32 from $38 at Roth Capital
DICE Dice Therapeutics
$31.69 /

+0.21 (+0.67%)

10/11/21 SVB Leerink
Dice Therapeutics initiated with an Outperform at SVB Leerink
10/11/21 Evercore ISI
Evercore ISI starts Dice Therapeutics at Outperform, sees 120% upside
10/11/21 BofA
Dice Therapeutics initiated with a Buy at BofA
10/11/21 Evercore ISI
Dice Therapeutics initiated with an Outperform at Evercore ISI
FLDM Fluidigm
$4.62 /

+0.115 (+2.55%)

05/12/21 Piper Sandler
Fluidigm price target lowered to $7 from $8 at Piper Sandler
02/11/21 Piper Sandler
Fluidigm price target lowered to $8 from $15 at Piper Sandler
12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
GBT Global Blood Therapeutics
$28.30 /

+0.31 (+1.11%)

10/06/21 Jefferies
Global Blood Therapeutics initiated with a Buy at Jefferies
08/04/21
Fly Intel: Top five analyst upgrades
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
IMTX Immatics
$11.39 /

+0.07 (+0.62%)

03/17/21 Chardan
Immatics' early TCR platform activity signals 'notable,' says Chardan
03/17/21 SVB Leerink
Immatics price target raised to $26 from $17 at SVB Leerink
HALO Halozyme
$32.89 /

-0.425 (-1.28%)

06/14/21
Fly Intel: Top five analyst initiations
06/14/21 Evercore ISI
Halozyme initiated with an Outperform at Evercore ISI
06/11/21 BMO Capital
Halozyme coverage transferred at BMO Capital
05/17/21 SVB Leerink
Halozyme initiated with an Outperform at SVB Leerink
IOVA Iovance Biotherapeutics
$18.70 /

+0.445 (+2.44%)

11/15/21 Oppenheimer
Iovance price target lowered to $31 from $38 at Oppenheimer
11/05/21 H.C. Wainwright
Iovance Biotherapeutics price target lowered to $43 from $46 at H.C. Wainwright
11/05/21 Piper Sandler
Iovance Biotherapeutics price target raised to $20 from $18 at Piper Sandler
06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
MDXG MiMedx
$7.00 /

-0.155 (-2.17%)

07/26/21 Northland
MiMedx initiated with an Outperform at Northland
03/19/21 H.C. Wainwright
MiMedx initiated with a Buy at H.C. Wainwright
NUVA NuVasive
$48.02 /

-1.19 (-2.42%)

11/15/21 Piper Sandler
Piper sees 'low' odds that Globus will try to buy NuVasive
11/10/21 Needham
NuVasive price target lowered to $64 from $73 at Needham
11/10/21 Citi
NuVasive price target lowered to $70 from $82 at Citi
10/28/21 Loop Capital
NuVasive initiated with a Hold at Loop Capital
ONTX Onconova
$3.01 /

-0.05 (-1.63%)

09/28/21 Guggenheim
Onconova price target lowered to $12 from $29 at Guggenheim
05/18/21 Guggenheim
Onconova initiated with a Buy at Guggenheim
12/22/20 Noble Capital
Onconova upgraded to Outperform from Market Perform at Noble Capital
PSNL Personalis
$13.58 /

-0.175 (-1.27%)

11/05/21 Morgan Stanley
Morgan Stanley downgrades Personalis, says upside unlikely until 2023
11/05/21 Morgan Stanley
Personalis downgraded to Equal Weight from Overweight at Morgan Stanley
11/03/21 Needham
Personalis downgraded to Hold from Buy at Needham
11/03/21 Needham
Personalis downgraded to Hold from Buy at Needham
QDEL Quidel
$147.25 /

-2.36 (-1.58%)

10/08/21 JPMorgan
Quidel price target raised to $80 from $70 at JPMorgan
09/17/21 Raymond James
U.S. contract awards 'major wins' for Quidel, OraSure, says Raymond James
07/26/21 Piper Sandler
Quidel agreement with Beckman removes overhang, says Piper Sandler
07/19/21 Raymond James
Quidel contract with Delaware could increase materially, says Raymond James
REGN Regeneron
$636.37 /

-17.98 (-2.75%)

11/30/21 H.C. Wainwright
Regeneron should be bought on today's selloff, says H.C. Wainwright
11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/18/21 BMO Capital
Regeneron assumed with an Outperform at BMO Capital
11/10/21 Cantor Fitzgerald
Regeneron price target raised to $760 from $700 at Cantor Fitzgerald
RVNC Revance
$13.69 /

+1.24 (+9.96%)

10/26/21 Barclays
Revance price target lowered to $22 from $33 at Barclays
10/25/21 Wells Fargo
Revance downgraded to Equal Weight from Overweight at Wells Fargo
10/25/21 Wells Fargo
Revance downgraded to Equal Weight from Overweight at Wells Fargo
10/18/21 Needham
Revance price target lowered to $25 from $45 at Needham
SEER Seer
$22.29 /

+0.76 (+3.53%)

10/14/21 Cowen
Seer coverage transferred at Cowen
08/13/21 Morgan Stanley
Seer price target lowered to $50 from $55 at Morgan Stanley
12/29/20 BofA
BofA starts Seer with Neutral after 239% post-IPO rally
12/29/20
Fly Intel: Top five analyst calls
SNSE Sensei Biotherapeutics
$6.93 /

+0.16 (+2.36%)

07/06/21 Piper Sandler
Sensei Biotherapeutics price target lowered to $12 from $25 at Piper Sandler
07/05/21 AlphaValue/Baader
Sensei Biotherapeutics downgraded to Add from Buy at AlphaValue
07/01/21 Berenberg
Berenberg downgrades Sensei to Hold on 'significant setback'
07/01/21 Berenberg
Sensei Biotherapeutics downgraded to Hold from Buy at Berenberg
TFX Teleflex
$297.56 /

-11.39 (-3.69%)

11/03/21 Piper Sandler
Glaukos 'big beneficiary' of final CMS ruling, says Piper Sandler
10/07/21
Fly Intel: Top five analyst downgrades
10/07/21 KeyBanc
KeyBanc downgrades Teleflex on lower UroLift visibility
10/07/21 KeyBanc
Teleflex downgraded to Sector Weight from Overweight at KeyBanc
TNYA Tenaya Therapeutics
$19.87 /

+1.17 (+6.26%)

10/25/21 Piper Sandler
Conviction in Tenaya Therapeutics stronger after ESGCT data, says Piper Sandler
08/24/21 Morgan Stanley
Tenaya Therapeutics initiated with an Overweight at Morgan Stanley
08/24/21 Chardan
Tenaya Therapeutics initiated with a Buy at Chardan
08/24/21 Morgan Stanley
Tenaya Therapeutics initiated with an Overweight at Morgan Stanley
VIVO Meridian Bioscience
$19.91 /

-0.17 (-0.85%)

02/24/21 H.C. Wainwright
Meridian Bioscience price target lowered to $32 from $34 at H.C. Wainwright
02/23/21 Piper Sandler
Piper keeps Overweight on Meridian Bioscience after EUA withdrawal
02/08/21 H.C. Wainwright
Meridian Bioscience price target raised to $34 from $30 at H.C. Wainwright
02/08/21 Piper Sandler
Meridian Bioscience price target raised to $34 from $26 at Piper Sandler
VIVO Meridian Bioscience
$19.91 /

-0.17 (-0.85%)

TNYA Tenaya Therapeutics
$19.87 /

+1.17 (+6.26%)

TFX Teleflex
$297.56 /

-11.39 (-3.69%)

SNSE Sensei Biotherapeutics
$6.93 /

+0.16 (+2.36%)

SEER Seer
$22.29 /

+0.76 (+3.53%)

RVNC Revance
$13.69 /

+1.24 (+9.96%)

REGN Regeneron
$636.37 /

-17.98 (-2.75%)

QDEL Quidel
$147.25 /

-2.36 (-1.58%)

PSNL Personalis
$13.58 /

-0.175 (-1.27%)

NUVA NuVasive
$48.02 /

-1.19 (-2.42%)

IOVA Iovance Biotherapeutics
$18.70 /

+0.445 (+2.44%)

IMTX Immatics
$11.39 /

+0.07 (+0.62%)

HALO Halozyme
$32.89 /

-0.425 (-1.28%)

GBT Global Blood Therapeutics
$28.30 /

+0.31 (+1.11%)

FLDM Fluidigm
$4.62 /

+0.115 (+2.55%)

DOCS Doximity
$67.60 /

+0.91 (+1.36%)

DMAC DiaMedica Therapeutics
$3.69 /

+0.05 (+1.37%)

DICE Dice Therapeutics
$31.69 /

+0.21 (+0.67%)

CYTK Cytokinetics
$39.30 /

+0.51 (+1.31%)

CUE Cue Biopharma
$12.27 /

+0.24 (+2.00%)

BXRX Baudax Bio
/

+

AQST Aquestive Therapeutics
$5.91 /

-0.16 (-2.64%)

ABEO Abeona Therapeutics
/

+

  • 24
    Sep
  • 15
    Sep
  • 30
    Jul
  • 21
    Jul
  • 24
    Jun
  • 11
    Feb
  • 04
    Feb
  • 27
    Jan
  • 28
    Jan
  • 04
    Dec
SEER Seer
$22.29 /

+0.76 (+3.53%)

REGN Regeneron
$636.37 /

-17.98 (-2.75%)

QDEL Quidel
$147.25 /

-2.36 (-1.58%)

NUVA NuVasive
$48.02 /

-1.19 (-2.42%)

FLDM Fluidigm
$4.62 /

+0.115 (+2.55%)

DOCS Doximity
$67.60 /

+0.91 (+1.36%)

VIVO Meridian Bioscience
$19.91 /

-0.17 (-0.85%)

TNYA Tenaya Therapeutics
$19.87 /

+1.17 (+6.26%)

TFX Teleflex
$297.56 /

-11.39 (-3.69%)

SNSE Sensei Biotherapeutics
$6.93 /

+0.16 (+2.36%)

SEER Seer
$22.29 /

+0.76 (+3.53%)

RVNC Revance
$13.69 /

+1.24 (+9.96%)

REGN Regeneron
$636.37 /

-17.98 (-2.75%)

QDEL Quidel
$147.25 /

-2.36 (-1.58%)

PSNL Personalis
$13.58 /

-0.175 (-1.27%)

ONTX Onconova
$3.01 /

-0.05 (-1.63%)

NUVA NuVasive
$48.02 /

-1.19 (-2.42%)

IOVA Iovance Biotherapeutics
$18.70 /

+0.445 (+2.44%)

HALO Halozyme
$32.89 /

-0.425 (-1.28%)

GBT Global Blood Therapeutics
$28.30 /

+0.31 (+1.11%)

FLDM Fluidigm
$4.62 /

+0.115 (+2.55%)

DOCS Doximity
$67.60 /

+0.91 (+1.36%)

DMAC DiaMedica Therapeutics
$3.69 /

+0.05 (+1.37%)

DICE Dice Therapeutics
$31.69 /

+0.21 (+0.67%)

CYTK Cytokinetics
$39.30 /

+0.51 (+1.31%)

BXRX Baudax Bio
/

+

REGN Regeneron
$636.37 /

-17.98 (-2.75%)

IOVA Iovance Biotherapeutics
$18.70 /

+0.445 (+2.44%)

IMTX Immatics
$11.39 /

+0.07 (+0.62%)

DOCS Doximity
$67.60 /

+0.91 (+1.36%)

Downgrade
Abeona Therapeutics downgraded to Market Perform from Outperform at SVB Leerink » 06:40
11/30/21
11/30
06:40
11/30/21
06:40
ABEO

Abeona Therapeutics

$0.65 /

-0.085 (-11.64%)

SVB Leerink analyst Mani…

SVB Leerink analyst Mani Foroohar downgraded Abeona Therapeutics to Market Perform from Outperform with a $1 price target.

ShowHide Related Items >><<
ABEO Abeona Therapeutics
$0.65 /

-0.085 (-11.64%)

ABEO Abeona Therapeutics
$0.65 /

-0.085 (-11.64%)

11/29/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $4 from $5 at H.C. Wainwright
07/19/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $5 from $8 at H.C. Wainwright
ABEO Abeona Therapeutics
$0.65 /

-0.085 (-11.64%)

Conference/Events
Piper Sandler to hold a virtual conference » 04:55
11/30/21
11/30
04:55
11/30/21
04:55
ABEO

Abeona Therapeutics

/

+

, AQST

Aquestive Therapeutics

$6.07 /

-0.29 (-4.56%)

, BXRX

Baudax Bio

/

+

, CYTK

Cytokinetics

$38.79 /

-0.38 (-0.97%)

, CUE

Cue Biopharma

$12.03 /

-0.86 (-6.67%)

, DOCS

Doximity

$66.69 /

+5.56 (+9.10%)

, DMAC

DiaMedica Therapeutics

$3.63 /

-0.135 (-3.59%)

, DICE

Dice Therapeutics

$31.39 /

-1.68 (-5.08%)

, FLDM

Fluidigm

$4.51 /

-0.195 (-4.15%)

, GBT

Global Blood Therapeutics

$27.99 /

-1.375 (-4.68%)

, IMTX

Immatics

$11.33 /

+0.05 (+0.44%)

, HALO

Halozyme

$33.31 /

-0.61 (-1.80%)

, IOVA

Iovance Biotherapeutics

$18.26 /

-0.23 (-1.24%)

, MDXG

MiMedx

$7.14 /

-0.2 (-2.72%)

, NUVA

NuVasive

$49.21 /

-1.4 (-2.77%)

, ONTX

Onconova

$3.06 /

-0.11 (-3.47%)

, PSNL

Personalis

$13.74 /

-0.27 (-1.93%)

, QDEL

Quidel

$149.61 /

+5.01 (+3.46%)

, REGN

Regeneron

$654.26 /

+9.38 (+1.45%)

, RVNC

Revance

$12.45 /

-0.4 (-3.11%)

, SEER

Seer

$21.53 /

-1.37 (-5.98%)

, SNSE

Sensei Biotherapeutics

$6.78 /

-0.79 (-10.44%)

, TFX

Teleflex

$308.95 /

+4 (+1.31%)

, TNYA

Tenaya Therapeutics

$18.70 /

-0.62 (-3.21%)

, VIVO

Meridian Bioscience

$20.11 /

-0.09 (-0.45%)

33rd Annual Healthcare…

33rd Annual Healthcare Virtual Conference to be held on November 29-December 2.

ShowHide Related Items >><<
VIVO Meridian Bioscience
$20.11 /

-0.09 (-0.45%)

TFX Teleflex
$308.95 /

+4 (+1.31%)

SNSE Sensei Biotherapeutics
$6.78 /

-0.79 (-10.44%)

SEER Seer
$21.53 /

-1.37 (-5.98%)

RVNC Revance
$12.45 /

-0.4 (-3.11%)

REGN Regeneron
$654.26 /

+9.38 (+1.45%)

QDEL Quidel
$149.61 /

+5.01 (+3.46%)

PSNL Personalis
$13.74 /

-0.27 (-1.93%)

ONTX Onconova
$3.06 /

-0.11 (-3.47%)

NUVA NuVasive
$49.21 /

-1.4 (-2.77%)

MDXG MiMedx
$7.14 /

-0.2 (-2.72%)

IOVA Iovance Biotherapeutics
$18.26 /

-0.23 (-1.24%)

IMTX Immatics
$11.33 /

+0.05 (+0.44%)

HALO Halozyme
$33.31 /

-0.61 (-1.80%)

GBT Global Blood Therapeutics
$27.99 /

-1.375 (-4.68%)

FLDM Fluidigm
$4.51 /

-0.195 (-4.15%)

DOCS Doximity
$66.69 /

+5.56 (+9.10%)

DMAC DiaMedica Therapeutics
$3.63 /

-0.135 (-3.59%)

DICE Dice Therapeutics
$31.39 /

-1.68 (-5.08%)

CYTK Cytokinetics
$38.79 /

-0.38 (-0.97%)

CUE Cue Biopharma
$12.03 /

-0.86 (-6.67%)

BXRX Baudax Bio
/

+

AQST Aquestive Therapeutics
$6.07 /

-0.29 (-4.56%)

ABEO Abeona Therapeutics
/

+

ABEO Abeona Therapeutics
/

+

11/29/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $4 from $5 at H.C. Wainwright
07/19/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $5 from $8 at H.C. Wainwright
AQST Aquestive Therapeutics
$6.07 /

-0.29 (-4.56%)

06/24/21 Lake Street
Aquestive approval likely by year-end after Libervant NDA, says Lake Street
04/06/21 RBC Capital
Aquestive Therapeutics transferred with an Outperform at RBC Capital
BXRX Baudax Bio
/

+

CYTK Cytokinetics
$38.79 /

-0.38 (-0.97%)

11/04/21 H.C. Wainwright
Cytokinetics price target raised to $62 from $58 at H.C. Wainwright
10/12/21 Cantor Fitzgerald
Cytokinetics price target raised to $57 from $48 at Cantor Fitzgerald
10/06/21 Jefferies
Cytokinetics initiated with a Buy at Jefferies
10/04/21 Piper Sandler
Cytokinetics set to make commercial impact, says Piper Sandler
CUE Cue Biopharma
$12.03 /

-0.86 (-6.67%)

DOCS Doximity
$66.69 /

+5.56 (+9.10%)

11/16/21 Baird
Baird starts 'unique asset' Doximity with Outperform, $84 target
11/16/21 Baird
Doximity initiated with an Outperform at Baird
11/10/21 Needham
Doximity price target raised to $90 from $62 at Needham
11/10/21 Canaccord
Doximity price target raised to $75 from $70 at Canaccord
DMAC DiaMedica Therapeutics
$3.63 /

-0.135 (-3.59%)

09/27/21 Roth Capital
DiaMedica price target lowered to $24 from $32 at Roth Capital
06/30/21 Maxim
DiaMedica Therapeutics price target lowered to $11 from $14 at Maxim
06/29/21 Lake Street
DiaMedica should be bought on weakness after CKD data, says Lake Street
06/29/21 Roth Capital
DiaMedica Therapeutics price target lowered to $32 from $38 at Roth Capital
DICE Dice Therapeutics
$31.39 /

-1.68 (-5.08%)

10/11/21 SVB Leerink
Dice Therapeutics initiated with an Outperform at SVB Leerink
10/11/21 Evercore ISI
Evercore ISI starts Dice Therapeutics at Outperform, sees 120% upside
10/11/21 BofA
Dice Therapeutics initiated with a Buy at BofA
10/11/21 Evercore ISI
Dice Therapeutics initiated with an Outperform at Evercore ISI
FLDM Fluidigm
$4.51 /

-0.195 (-4.15%)

05/12/21 Piper Sandler
Fluidigm price target lowered to $7 from $8 at Piper Sandler
02/11/21 Piper Sandler
Fluidigm price target lowered to $8 from $15 at Piper Sandler
12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
GBT Global Blood Therapeutics
$27.99 /

-1.375 (-4.68%)

10/06/21 Jefferies
Global Blood Therapeutics initiated with a Buy at Jefferies
08/04/21
Fly Intel: Top five analyst upgrades
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
IMTX Immatics
$11.33 /

+0.05 (+0.44%)

03/17/21 Chardan
Immatics' early TCR platform activity signals 'notable,' says Chardan
03/17/21 SVB Leerink
Immatics price target raised to $26 from $17 at SVB Leerink
HALO Halozyme
$33.31 /

-0.61 (-1.80%)

06/14/21
Fly Intel: Top five analyst initiations
06/14/21 Evercore ISI
Halozyme initiated with an Outperform at Evercore ISI
06/11/21 BMO Capital
Halozyme coverage transferred at BMO Capital
05/17/21 SVB Leerink
Halozyme initiated with an Outperform at SVB Leerink
IOVA Iovance Biotherapeutics
$18.26 /

-0.23 (-1.24%)

11/15/21 Oppenheimer
Iovance price target lowered to $31 from $38 at Oppenheimer
11/05/21 H.C. Wainwright
Iovance Biotherapeutics price target lowered to $43 from $46 at H.C. Wainwright
11/05/21 Piper Sandler
Iovance Biotherapeutics price target raised to $20 from $18 at Piper Sandler
06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
MDXG MiMedx
$7.14 /

-0.2 (-2.72%)

07/26/21 Northland
MiMedx initiated with an Outperform at Northland
03/19/21 H.C. Wainwright
MiMedx initiated with a Buy at H.C. Wainwright
NUVA NuVasive
$49.21 /

-1.4 (-2.77%)

11/15/21 Piper Sandler
Piper sees 'low' odds that Globus will try to buy NuVasive
11/10/21 Needham
NuVasive price target lowered to $64 from $73 at Needham
11/10/21 Citi
NuVasive price target lowered to $70 from $82 at Citi
10/28/21 Loop Capital
NuVasive initiated with a Hold at Loop Capital
ONTX Onconova
$3.06 /

-0.11 (-3.47%)

09/28/21 Guggenheim
Onconova price target lowered to $12 from $29 at Guggenheim
05/18/21 Guggenheim
Onconova initiated with a Buy at Guggenheim
12/22/20 Noble Capital
Onconova upgraded to Outperform from Market Perform at Noble Capital
PSNL Personalis
$13.74 /

-0.27 (-1.93%)

11/05/21 Morgan Stanley
Morgan Stanley downgrades Personalis, says upside unlikely until 2023
11/05/21 Morgan Stanley
Personalis downgraded to Equal Weight from Overweight at Morgan Stanley
11/03/21 Needham
Personalis downgraded to Hold from Buy at Needham
11/03/21 Needham
Personalis downgraded to Hold from Buy at Needham
QDEL Quidel
$149.61 /

+5.01 (+3.46%)

10/08/21 JPMorgan
Quidel price target raised to $80 from $70 at JPMorgan
09/17/21 Raymond James
U.S. contract awards 'major wins' for Quidel, OraSure, says Raymond James
07/26/21 Piper Sandler
Quidel agreement with Beckman removes overhang, says Piper Sandler
07/19/21 Raymond James
Quidel contract with Delaware could increase materially, says Raymond James
REGN Regeneron
$654.26 /

+9.38 (+1.45%)

11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/18/21 BMO Capital
Regeneron assumed with an Outperform at BMO Capital
11/10/21 Cantor Fitzgerald
Regeneron price target raised to $760 from $700 at Cantor Fitzgerald
11/09/21 Benchmark
Benchmark sees signs Regeneron may be planning large acquisition
RVNC Revance
$12.45 /

-0.4 (-3.11%)

10/26/21 Barclays
Revance price target lowered to $22 from $33 at Barclays
10/25/21 Wells Fargo
Revance downgraded to Equal Weight from Overweight at Wells Fargo
10/25/21 Wells Fargo
Revance downgraded to Equal Weight from Overweight at Wells Fargo
10/18/21 Needham
Revance price target lowered to $25 from $45 at Needham
SEER Seer
$21.53 /

-1.37 (-5.98%)

10/14/21 Cowen
Seer coverage transferred at Cowen
08/13/21 Morgan Stanley
Seer price target lowered to $50 from $55 at Morgan Stanley
12/29/20 BofA
BofA starts Seer with Neutral after 239% post-IPO rally
12/29/20
Fly Intel: Top five analyst calls
SNSE Sensei Biotherapeutics
$6.78 /

-0.79 (-10.44%)

07/06/21 Piper Sandler
Sensei Biotherapeutics price target lowered to $12 from $25 at Piper Sandler
07/05/21 AlphaValue/Baader
Sensei Biotherapeutics downgraded to Add from Buy at AlphaValue
07/01/21 Berenberg
Berenberg downgrades Sensei to Hold on 'significant setback'
07/01/21 Berenberg
Sensei Biotherapeutics downgraded to Hold from Buy at Berenberg
TFX Teleflex
$308.95 /

+4 (+1.31%)

11/03/21 Piper Sandler
Glaukos 'big beneficiary' of final CMS ruling, says Piper Sandler
10/07/21
Fly Intel: Top five analyst downgrades
10/07/21 KeyBanc
KeyBanc downgrades Teleflex on lower UroLift visibility
10/07/21 KeyBanc
Teleflex downgraded to Sector Weight from Overweight at KeyBanc
TNYA Tenaya Therapeutics
$18.70 /

-0.62 (-3.21%)

10/25/21 Piper Sandler
Conviction in Tenaya Therapeutics stronger after ESGCT data, says Piper Sandler
08/24/21 Morgan Stanley
Tenaya Therapeutics initiated with an Overweight at Morgan Stanley
08/24/21 Chardan
Tenaya Therapeutics initiated with a Buy at Chardan
08/24/21 Morgan Stanley
Tenaya Therapeutics initiated with an Overweight at Morgan Stanley
VIVO Meridian Bioscience
$20.11 /

-0.09 (-0.45%)

02/24/21 H.C. Wainwright
Meridian Bioscience price target lowered to $32 from $34 at H.C. Wainwright
02/23/21 Piper Sandler
Piper keeps Overweight on Meridian Bioscience after EUA withdrawal
02/08/21 H.C. Wainwright
Meridian Bioscience price target raised to $34 from $30 at H.C. Wainwright
02/08/21 Piper Sandler
Meridian Bioscience price target raised to $34 from $26 at Piper Sandler
VIVO Meridian Bioscience
$20.11 /

-0.09 (-0.45%)

TNYA Tenaya Therapeutics
$18.70 /

-0.62 (-3.21%)

TFX Teleflex
$308.95 /

+4 (+1.31%)

SNSE Sensei Biotherapeutics
$6.78 /

-0.79 (-10.44%)

SEER Seer
$21.53 /

-1.37 (-5.98%)

RVNC Revance
$12.45 /

-0.4 (-3.11%)

REGN Regeneron
$654.26 /

+9.38 (+1.45%)

QDEL Quidel
$149.61 /

+5.01 (+3.46%)

PSNL Personalis
$13.74 /

-0.27 (-1.93%)

NUVA NuVasive
$49.21 /

-1.4 (-2.77%)

IOVA Iovance Biotherapeutics
$18.26 /

-0.23 (-1.24%)

IMTX Immatics
$11.33 /

+0.05 (+0.44%)

HALO Halozyme
$33.31 /

-0.61 (-1.80%)

GBT Global Blood Therapeutics
$27.99 /

-1.375 (-4.68%)

FLDM Fluidigm
$4.51 /

-0.195 (-4.15%)

DOCS Doximity
$66.69 /

+5.56 (+9.10%)

DMAC DiaMedica Therapeutics
$3.63 /

-0.135 (-3.59%)

DICE Dice Therapeutics
$31.39 /

-1.68 (-5.08%)

CYTK Cytokinetics
$38.79 /

-0.38 (-0.97%)

CUE Cue Biopharma
$12.03 /

-0.86 (-6.67%)

BXRX Baudax Bio
/

+

AQST Aquestive Therapeutics
$6.07 /

-0.29 (-4.56%)

ABEO Abeona Therapeutics
/

+

  • 24
    Sep
  • 15
    Sep
  • 30
    Jul
  • 21
    Jul
  • 24
    Jun
  • 11
    Feb
  • 04
    Feb
  • 27
    Jan
  • 28
    Jan
  • 04
    Dec
SEER Seer
$21.53 /

-1.37 (-5.98%)

REGN Regeneron
$654.26 /

+9.38 (+1.45%)

QDEL Quidel
$149.61 /

+5.01 (+3.46%)

NUVA NuVasive
$49.21 /

-1.4 (-2.77%)

FLDM Fluidigm
$4.51 /

-0.195 (-4.15%)

DOCS Doximity
$66.69 /

+5.56 (+9.10%)

VIVO Meridian Bioscience
$20.11 /

-0.09 (-0.45%)

TNYA Tenaya Therapeutics
$18.70 /

-0.62 (-3.21%)

TFX Teleflex
$308.95 /

+4 (+1.31%)

SNSE Sensei Biotherapeutics
$6.78 /

-0.79 (-10.44%)

SEER Seer
$21.53 /

-1.37 (-5.98%)

RVNC Revance
$12.45 /

-0.4 (-3.11%)

REGN Regeneron
$654.26 /

+9.38 (+1.45%)

QDEL Quidel
$149.61 /

+5.01 (+3.46%)

PSNL Personalis
$13.74 /

-0.27 (-1.93%)

ONTX Onconova
$3.06 /

-0.11 (-3.47%)

NUVA NuVasive
$49.21 /

-1.4 (-2.77%)

IOVA Iovance Biotherapeutics
$18.26 /

-0.23 (-1.24%)

HALO Halozyme
$33.31 /

-0.61 (-1.80%)

GBT Global Blood Therapeutics
$27.99 /

-1.375 (-4.68%)

FLDM Fluidigm
$4.51 /

-0.195 (-4.15%)

DOCS Doximity
$66.69 /

+5.56 (+9.10%)

DMAC DiaMedica Therapeutics
$3.63 /

-0.135 (-3.59%)

DICE Dice Therapeutics
$31.39 /

-1.68 (-5.08%)

CYTK Cytokinetics
$38.79 /

-0.38 (-0.97%)

BXRX Baudax Bio
/

+

REGN Regeneron
$654.26 /

+9.38 (+1.45%)

IOVA Iovance Biotherapeutics
$18.26 /

-0.23 (-1.24%)

IMTX Immatics
$11.33 /

+0.05 (+0.44%)

DOCS Doximity
$66.69 /

+5.56 (+9.10%)

Conference/Events
Piper Sandler to hold a virtual conference » 10:34
11/29/21
11/29
10:34
11/29/21
10:34
ABEO

Abeona Therapeutics

/

+

, AQST

Aquestive Therapeutics

$6.27 /

-0.09 (-1.42%)

, BXRX

Baudax Bio

/

+

, CYTK

Cytokinetics

$39.93 /

+0.76 (+1.94%)

, CUE

Cue Biopharma

$12.79 /

-0.1 (-0.78%)

, DOCS

Doximity

$65.64 /

+4.51 (+7.38%)

, DMAC

DiaMedica Therapeutics

$3.78 /

+0.015 (+0.40%)

, DICE

Dice Therapeutics

$32.28 /

-0.79 (-2.39%)

, FLDM

Fluidigm

$4.50 /

-0.2 (-4.26%)

, GBT

Global Blood Therapeutics

$29.05 /

-0.315 (-1.07%)

, IMTX

Immatics

$11.32 /

+0.04 (+0.35%)

, HALO

Halozyme

$33.94 /

+0.02 (+0.06%)

, IOVA

Iovance Biotherapeutics

$18.40 /

-0.09 (-0.49%)

, MDXG

MiMedx

$7.39 /

+0.05 (+0.68%)

, NUVA

NuVasive

$51.00 /

+0.39 (+0.77%)

, ONTX

Onconova

$3.12 /

-0.05 (-1.58%)

, PSNL

Personalis

$13.73 /

-0.28 (-2.00%)

, QDEL

Quidel

$146.00 /

+1.4 (+0.97%)

, REGN

Regeneron

$647.50 /

+2.62 (+0.41%)

, RVNC

Revance

$12.80 /

-0.05 (-0.39%)

, SEER

Seer

$22.23 /

-0.67 (-2.93%)

, SNSE

Sensei Biotherapeutics

$7.80 /

+0.23 (+3.04%)

, TFX

Teleflex

$311.52 /

+6.57 (+2.15%)

, TNYA

Tenaya Therapeutics

$18.95 /

-0.37 (-1.92%)

, VIVO

Meridian Bioscience

$20.13 /

-0.07 (-0.35%)

33rd Annual Healthcare…

33rd Annual Healthcare Virtual Conference to be held on November 29-December 2.

ShowHide Related Items >><<
VIVO Meridian Bioscience
$20.13 /

-0.07 (-0.35%)

TFX Teleflex
$311.52 /

+6.57 (+2.15%)

SNSE Sensei Biotherapeutics
$7.80 /

+0.23 (+3.04%)

SEER Seer
$22.23 /

-0.67 (-2.93%)

RVNC Revance
$12.80 /

-0.05 (-0.39%)

REGN Regeneron
$647.50 /

+2.62 (+0.41%)

QDEL Quidel
$146.00 /

+1.4 (+0.97%)

PSNL Personalis
$13.73 /

-0.28 (-2.00%)

ONTX Onconova
$3.12 /

-0.05 (-1.58%)

NUVA NuVasive
$51.00 /

+0.39 (+0.77%)

MDXG MiMedx
$7.39 /

+0.05 (+0.68%)

IOVA Iovance Biotherapeutics
$18.40 /

-0.09 (-0.49%)

IMTX Immatics
$11.32 /

+0.04 (+0.35%)

HALO Halozyme
$33.94 /

+0.02 (+0.06%)

GBT Global Blood Therapeutics
$29.05 /

-0.315 (-1.07%)

FLDM Fluidigm
$4.50 /

-0.2 (-4.26%)

DOCS Doximity
$65.64 /

+4.51 (+7.38%)

DMAC DiaMedica Therapeutics
$3.78 /

+0.015 (+0.40%)

DICE Dice Therapeutics
$32.28 /

-0.79 (-2.39%)

CYTK Cytokinetics
$39.93 /

+0.76 (+1.94%)

CUE Cue Biopharma
$12.79 /

-0.1 (-0.78%)

BXRX Baudax Bio
/

+

AQST Aquestive Therapeutics
$6.27 /

-0.09 (-1.42%)

ABEO Abeona Therapeutics
/

+

ABEO Abeona Therapeutics
/

+

11/29/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $4 from $5 at H.C. Wainwright
07/19/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $5 from $8 at H.C. Wainwright
AQST Aquestive Therapeutics
$6.27 /

-0.09 (-1.42%)

06/24/21 Lake Street
Aquestive approval likely by year-end after Libervant NDA, says Lake Street
04/06/21 RBC Capital
Aquestive Therapeutics transferred with an Outperform at RBC Capital
BXRX Baudax Bio
/

+

CYTK Cytokinetics
$39.93 /

+0.76 (+1.94%)

11/04/21 H.C. Wainwright
Cytokinetics price target raised to $62 from $58 at H.C. Wainwright
10/12/21 Cantor Fitzgerald
Cytokinetics price target raised to $57 from $48 at Cantor Fitzgerald
10/06/21 Jefferies
Cytokinetics initiated with a Buy at Jefferies
10/04/21 Piper Sandler
Cytokinetics set to make commercial impact, says Piper Sandler
CUE Cue Biopharma
$12.79 /

-0.1 (-0.78%)

DOCS Doximity
$65.64 /

+4.51 (+7.38%)

11/16/21 Baird
Baird starts 'unique asset' Doximity with Outperform, $84 target
11/16/21 Baird
Doximity initiated with an Outperform at Baird
11/10/21 Needham
Doximity price target raised to $90 from $62 at Needham
11/10/21 Canaccord
Doximity price target raised to $75 from $70 at Canaccord
DMAC DiaMedica Therapeutics
$3.78 /

+0.015 (+0.40%)

09/27/21 Roth Capital
DiaMedica price target lowered to $24 from $32 at Roth Capital
06/30/21 Maxim
DiaMedica Therapeutics price target lowered to $11 from $14 at Maxim
06/29/21 Lake Street
DiaMedica should be bought on weakness after CKD data, says Lake Street
06/29/21 Roth Capital
DiaMedica Therapeutics price target lowered to $32 from $38 at Roth Capital
DICE Dice Therapeutics
$32.28 /

-0.79 (-2.39%)

10/11/21 SVB Leerink
Dice Therapeutics initiated with an Outperform at SVB Leerink
10/11/21 Evercore ISI
Evercore ISI starts Dice Therapeutics at Outperform, sees 120% upside
10/11/21 BofA
Dice Therapeutics initiated with a Buy at BofA
10/11/21 Evercore ISI
Dice Therapeutics initiated with an Outperform at Evercore ISI
FLDM Fluidigm
$4.50 /

-0.2 (-4.26%)

05/12/21 Piper Sandler
Fluidigm price target lowered to $7 from $8 at Piper Sandler
02/11/21 Piper Sandler
Fluidigm price target lowered to $8 from $15 at Piper Sandler
12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
GBT Global Blood Therapeutics
$29.05 /

-0.315 (-1.07%)

10/06/21 Jefferies
Global Blood Therapeutics initiated with a Buy at Jefferies
08/04/21
Fly Intel: Top five analyst upgrades
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
IMTX Immatics
$11.32 /

+0.04 (+0.35%)

03/17/21 Chardan
Immatics' early TCR platform activity signals 'notable,' says Chardan
03/17/21 SVB Leerink
Immatics price target raised to $26 from $17 at SVB Leerink
HALO Halozyme
$33.94 /

+0.02 (+0.06%)

06/14/21
Fly Intel: Top five analyst initiations
06/14/21 Evercore ISI
Halozyme initiated with an Outperform at Evercore ISI
06/11/21 BMO Capital
Halozyme coverage transferred at BMO Capital
05/17/21 SVB Leerink
Halozyme initiated with an Outperform at SVB Leerink
IOVA Iovance Biotherapeutics
$18.40 /

-0.09 (-0.49%)

11/15/21 Oppenheimer
Iovance price target lowered to $31 from $38 at Oppenheimer
11/05/21 H.C. Wainwright
Iovance Biotherapeutics price target lowered to $43 from $46 at H.C. Wainwright
11/05/21 Piper Sandler
Iovance Biotherapeutics price target raised to $20 from $18 at Piper Sandler
06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
MDXG MiMedx
$7.39 /

+0.05 (+0.68%)

07/26/21 Northland
MiMedx initiated with an Outperform at Northland
03/19/21 H.C. Wainwright
MiMedx initiated with a Buy at H.C. Wainwright
NUVA NuVasive
$51.00 /

+0.39 (+0.77%)

11/15/21 Piper Sandler
Piper sees 'low' odds that Globus will try to buy NuVasive
11/10/21 Needham
NuVasive price target lowered to $64 from $73 at Needham
11/10/21 Citi
NuVasive price target lowered to $70 from $82 at Citi
10/28/21 Loop Capital
NuVasive initiated with a Hold at Loop Capital
ONTX Onconova
$3.12 /

-0.05 (-1.58%)

09/28/21 Guggenheim
Onconova price target lowered to $12 from $29 at Guggenheim
05/18/21 Guggenheim
Onconova initiated with a Buy at Guggenheim
12/22/20 Noble Capital
Onconova upgraded to Outperform from Market Perform at Noble Capital
PSNL Personalis
$13.73 /

-0.28 (-2.00%)

11/05/21 Morgan Stanley
Morgan Stanley downgrades Personalis, says upside unlikely until 2023
11/05/21 Morgan Stanley
Personalis downgraded to Equal Weight from Overweight at Morgan Stanley
11/03/21 Needham
Personalis downgraded to Hold from Buy at Needham
11/03/21 Needham
Personalis downgraded to Hold from Buy at Needham
QDEL Quidel
$146.00 /

+1.4 (+0.97%)

10/08/21 JPMorgan
Quidel price target raised to $80 from $70 at JPMorgan
09/17/21 Raymond James
U.S. contract awards 'major wins' for Quidel, OraSure, says Raymond James
07/26/21 Piper Sandler
Quidel agreement with Beckman removes overhang, says Piper Sandler
07/19/21 Raymond James
Quidel contract with Delaware could increase materially, says Raymond James
REGN Regeneron
$647.50 /

+2.62 (+0.41%)

11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/18/21 BMO Capital
Regeneron assumed with an Outperform at BMO Capital
11/10/21 Cantor Fitzgerald
Regeneron price target raised to $760 from $700 at Cantor Fitzgerald
11/09/21 Benchmark
Benchmark sees signs Regeneron may be planning large acquisition
RVNC Revance
$12.80 /

-0.05 (-0.39%)

10/26/21 Barclays
Revance price target lowered to $22 from $33 at Barclays
10/25/21 Wells Fargo
Revance downgraded to Equal Weight from Overweight at Wells Fargo
10/25/21 Wells Fargo
Revance downgraded to Equal Weight from Overweight at Wells Fargo
10/18/21 Needham
Revance price target lowered to $25 from $45 at Needham
SEER Seer
$22.23 /

-0.67 (-2.93%)

10/14/21 Cowen
Seer coverage transferred at Cowen
08/13/21 Morgan Stanley
Seer price target lowered to $50 from $55 at Morgan Stanley
12/29/20 BofA
BofA starts Seer with Neutral after 239% post-IPO rally
12/29/20
Fly Intel: Top five analyst calls
SNSE Sensei Biotherapeutics
$7.80 /

+0.23 (+3.04%)

07/06/21 Piper Sandler
Sensei Biotherapeutics price target lowered to $12 from $25 at Piper Sandler
07/05/21 AlphaValue/Baader
Sensei Biotherapeutics downgraded to Add from Buy at AlphaValue
07/01/21 Berenberg
Berenberg downgrades Sensei to Hold on 'significant setback'
07/01/21 Berenberg
Sensei Biotherapeutics downgraded to Hold from Buy at Berenberg
TFX Teleflex
$311.52 /

+6.57 (+2.15%)

11/03/21 Piper Sandler
Glaukos 'big beneficiary' of final CMS ruling, says Piper Sandler
10/07/21
Fly Intel: Top five analyst downgrades
10/07/21 KeyBanc
KeyBanc downgrades Teleflex on lower UroLift visibility
10/07/21 KeyBanc
Teleflex downgraded to Sector Weight from Overweight at KeyBanc
TNYA Tenaya Therapeutics
$18.95 /

-0.37 (-1.92%)

10/25/21 Piper Sandler
Conviction in Tenaya Therapeutics stronger after ESGCT data, says Piper Sandler
08/24/21 Morgan Stanley
Tenaya Therapeutics initiated with an Overweight at Morgan Stanley
08/24/21 Chardan
Tenaya Therapeutics initiated with a Buy at Chardan
08/24/21 Morgan Stanley
Tenaya Therapeutics initiated with an Overweight at Morgan Stanley
VIVO Meridian Bioscience
$20.13 /

-0.07 (-0.35%)

02/24/21 H.C. Wainwright
Meridian Bioscience price target lowered to $32 from $34 at H.C. Wainwright
02/23/21 Piper Sandler
Piper keeps Overweight on Meridian Bioscience after EUA withdrawal
02/08/21 H.C. Wainwright
Meridian Bioscience price target raised to $34 from $30 at H.C. Wainwright
02/08/21 Piper Sandler
Meridian Bioscience price target raised to $34 from $26 at Piper Sandler
VIVO Meridian Bioscience
$20.13 /

-0.07 (-0.35%)

TNYA Tenaya Therapeutics
$18.95 /

-0.37 (-1.92%)

TFX Teleflex
$311.52 /

+6.57 (+2.15%)

SNSE Sensei Biotherapeutics
$7.80 /

+0.23 (+3.04%)

SEER Seer
$22.23 /

-0.67 (-2.93%)

RVNC Revance
$12.80 /

-0.05 (-0.39%)

REGN Regeneron
$647.50 /

+2.62 (+0.41%)

QDEL Quidel
$146.00 /

+1.4 (+0.97%)

PSNL Personalis
$13.73 /

-0.28 (-2.00%)

NUVA NuVasive
$51.00 /

+0.39 (+0.77%)

IOVA Iovance Biotherapeutics
$18.40 /

-0.09 (-0.49%)

IMTX Immatics
$11.32 /

+0.04 (+0.35%)

HALO Halozyme
$33.94 /

+0.02 (+0.06%)

GBT Global Blood Therapeutics
$29.05 /

-0.315 (-1.07%)

FLDM Fluidigm
$4.50 /

-0.2 (-4.26%)

DOCS Doximity
$65.64 /

+4.51 (+7.38%)

DMAC DiaMedica Therapeutics
$3.78 /

+0.015 (+0.40%)

DICE Dice Therapeutics
$32.28 /

-0.79 (-2.39%)

CYTK Cytokinetics
$39.93 /

+0.76 (+1.94%)

CUE Cue Biopharma
$12.79 /

-0.1 (-0.78%)

BXRX Baudax Bio
/

+

AQST Aquestive Therapeutics
$6.27 /

-0.09 (-1.42%)

ABEO Abeona Therapeutics
/

+

  • 24
    Sep
  • 15
    Sep
  • 30
    Jul
  • 21
    Jul
  • 24
    Jun
  • 11
    Feb
  • 04
    Feb
  • 27
    Jan
  • 28
    Jan
  • 04
    Dec
SEER Seer
$22.23 /

-0.67 (-2.93%)

QDEL Quidel
$146.00 /

+1.4 (+0.97%)

NUVA NuVasive
$51.00 /

+0.39 (+0.77%)

FLDM Fluidigm
$4.50 /

-0.2 (-4.26%)

DOCS Doximity
$65.64 /

+4.51 (+7.38%)

VIVO Meridian Bioscience
$20.13 /

-0.07 (-0.35%)

TNYA Tenaya Therapeutics
$18.95 /

-0.37 (-1.92%)

TFX Teleflex
$311.52 /

+6.57 (+2.15%)

SNSE Sensei Biotherapeutics
$7.80 /

+0.23 (+3.04%)

SEER Seer
$22.23 /

-0.67 (-2.93%)

RVNC Revance
$12.80 /

-0.05 (-0.39%)

REGN Regeneron
$647.50 /

+2.62 (+0.41%)

QDEL Quidel
$146.00 /

+1.4 (+0.97%)

PSNL Personalis
$13.73 /

-0.28 (-2.00%)

ONTX Onconova
$3.12 /

-0.05 (-1.58%)

NUVA NuVasive
$51.00 /

+0.39 (+0.77%)

IOVA Iovance Biotherapeutics
$18.40 /

-0.09 (-0.49%)

HALO Halozyme
$33.94 /

+0.02 (+0.06%)

GBT Global Blood Therapeutics
$29.05 /

-0.315 (-1.07%)

FLDM Fluidigm
$4.50 /

-0.2 (-4.26%)

DOCS Doximity
$65.64 /

+4.51 (+7.38%)

DMAC DiaMedica Therapeutics
$3.78 /

+0.015 (+0.40%)

DICE Dice Therapeutics
$32.28 /

-0.79 (-2.39%)

CYTK Cytokinetics
$39.93 /

+0.76 (+1.94%)

BXRX Baudax Bio
/

+

REGN Regeneron
$647.50 /

+2.62 (+0.41%)

IOVA Iovance Biotherapeutics
$18.40 /

-0.09 (-0.49%)

IMTX Immatics
$11.32 /

+0.04 (+0.35%)

DOCS Doximity
$65.64 /

+4.51 (+7.38%)

Recommendations
Abeona Therapeutics price target lowered to $4 from $5 at H.C. Wainwright » 06:16
11/29/21
11/29
06:16
11/29/21
06:16
ABEO

Abeona Therapeutics

/

+

H.C. Wainwright analyst…

H.C. Wainwright analyst Raghuram Selvaraju lowered the firm's price target on Abeona Therapeutics to $4 from $5 and keeps a Buy rating on the shares post the Q3 results.

ShowHide Related Items >><<
ABEO Abeona Therapeutics
/

+

ABEO Abeona Therapeutics
/

+

07/19/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $5 from $8 at H.C. Wainwright
ABEO Abeona Therapeutics
/

+

Hot Stocks
Abeona Therapeutics announces sponsorship of Venture Into Cures » 07:35
11/18/21
11/18
07:35
11/18/21
07:35
ABEO

Abeona Therapeutics

/

+

Abeona Therapeutics…

Abeona Therapeutics announced its sponsorship of the second annual Venture Into Cures, a virtual event supporting EB Research Partnership's mission to find a cure for epidermolysis bullosa. The event will take place virtually on November 18, 2021 at 8:00 p.m. ET/ 5:00 p.m. PT. The one-hour show will feature inspiring stories about individuals and families living with EB and bring together world-renowned speakers alongside appearances and performances from a lineup of celebrity supporters, to educate viewers about EB and raise funds for critical research towards finding treatments and cures for EB. Venture Into Cures will stream globally for free at www.ventureintocures.org.

ShowHide Related Items >><<
ABEO Abeona Therapeutics
/

+

ABEO Abeona Therapeutics
/

+

07/19/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $5 from $8 at H.C. Wainwright
11/25/20 H.C. Wainwright
Abeona Therapeutics price target lowered to $8 from $11 at H.C. Wainwright
ABEO Abeona Therapeutics
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.